CD33 and myelodysplastic syndrome: It was first documented by Chen et al., and later also reported by other groups, that MDSCs accumulate in the BM of patients with MDS, as indicated by the increased proportion of the Lin-/CD33+/CD11b+/DR− population in MDS patient peripheral blood (PB) and BM samples [78,79,80,81,82].